ANÁPOLIS, BR / ACCESS Newswire / December 28, 2025 / Brook S/A, a Brazilian pharmaceutical company led by entrepreneur Wesley ...
DUBLIN--(BUSINESS WIRE)--The "Active Pharmaceutical Ingredients (APIs) Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global active ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Specialty Active Pharmaceutical Ingredients (API) Market: Global Industry Analysis and Opportunity Assessment, ...
Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Active Pharmaceutical Ingredients (APIs) Market - Growth, Trends & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's ...
NORTH CHICAGO, Ill., Aug. 12, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ...
Jan 31 (Reuters) - Teva Pharmaceutical Industries TEVA.TA will divest its active pharmaceutical ingredient (API) unit to focus on its core business, the world's largest generic drugs maker said on ...
U.S. President Donald Trump issued another executive order: "Strategically stockpile the raw materials needed to make ...
TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active ...
The world’s number two producer of active pharmaceutical ingredients (APIs) is for sale. Given the constant global demand for essential medicines, the business might seem like a lucrative asset. But ...
License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback